ClinicalTrials.gov
ClinicalTrials.gov Menu

Survey of Prevalence of Loss of Appetite in Subject With Health Disorders (SPLASH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01592149
Recruitment Status : Completed
First Posted : May 7, 2012
Last Update Posted : February 11, 2015
Sponsor:
Information provided by (Responsible Party):
Bayer

Brief Summary:
The study is an epidemiological survey to find out the incidence of loss of appetite in Indian patients suffering from various health disorders. This survey will be conducted to obtain information on appetite from a total of 17500 subjects This study does not intend to study the effect of any drugs. The primary source of information will be the subjects themselves. The study will be conducted at 275 - 350 centres spread across India.This is a single visit study.The physician will conduct routine clinical, physical and general examination.

Condition or disease Intervention/treatment
Appetite Other: No Drug

Study Type : Observational
Actual Enrollment : 16629 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Survey of Prevalence of Loss of Appetite in Subject With Health Disorders.
Study Start Date : May 2012
Actual Primary Completion Date : March 2014
Actual Study Completion Date : January 2015

Group/Cohort Intervention/treatment
Group 1 Other: No Drug
No intervention will be given to subjects, survey of loss of appetite in patients suffering from various healthcare disorders.



Primary Outcome Measures :
  1. Percentage of patients with loss of appetite [ Time Frame: 1 Day ]

Secondary Outcome Measures :
  1. Percentage of patients with fatigue [ Time Frame: 1 Day ]
  2. Distribution of fatigue among the patients with respect to disease [ Time Frame: 1 Day ]
  3. Percentage of patients with moderate to very severe Fatigue. [ Time Frame: 1 Day ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patient with various health related disoder
Criteria

Inclusion Criteria:

  • Men and Non-pregnant women ≥ 18 years of age recuperating from healthcare disorders like:Malaria fever, Typhoid or enteric fever
  • Hepatitis
  • Acute infections including respiratory, urinary tract infections etc treated with antibiotic
  • Tuberculosis
  • Patient discharged from hospital after general surgical procedures like acute appendectomy, etc.
  • Any other condition

Exclusion Criteria:

  • Patients unwilling to provide informed consent & comply with the study procedure
  • Patient using drugs which affect appetite like Cyproheptadine etc.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01592149


Locations
India
Many Locations, India
Sponsors and Collaborators
Bayer
Investigators
Study Director: Bayer Study Director Bayer

Additional Information:
Responsible Party: Bayer
ClinicalTrials.gov Identifier: NCT01592149     History of Changes
Other Study ID Numbers: 16235
First Posted: May 7, 2012    Key Record Dates
Last Update Posted: February 11, 2015
Last Verified: February 2015

Keywords provided by Bayer:
Appetite

Additional relevant MeSH terms:
Anorexia
Signs and Symptoms, Digestive
Signs and Symptoms